These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 17148998)

  • 1. Effect of regression of enlarged neck lymph nodes on radiation doses received by parotid glands during intensity-modulated radiotherapy for head and neck cancer.
    Kuo YC; Wu TH; Chung TS; Huang KW; Chao KS; Su WC; Chiou JF
    Am J Clin Oncol; 2006 Dec; 29(6):600-5. PubMed ID: 17148998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
    Eisbruch A; Marsh LH; Dawson LA; Bradford CR; Teknos TN; Chepeha DB; Worden FP; Urba S; Lin A; Schipper MJ; Wolf GT
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):28-42. PubMed ID: 15093896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study.
    Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Kirwan J; Mendenhall WM
    Laryngoscope; 2009 Oct; 119(10):1966-74. PubMed ID: 19688858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parotid gland sparing with helical tomotherapy in head-and-neck cancer.
    Voordeckers M; Farrag A; Everaert H; Tournel K; Storme G; Verellen D; De Ridder M
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):443-8. PubMed ID: 22836056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy.
    Münter MW; Karger CP; Hoffner SG; Hof H; Thilmann C; Rudat V; Nill S; Wannenmacher M; Debus J
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):175-84. PubMed ID: 14697436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of the initial volume of parotid glands in xerostomia for patients with head and neck cancers treated with IMRT.
    Nishimura Y; Nakamatsu K; Shibata T; Kanamori S; Koike R; Okumura M; Suzuki M
    Jpn J Clin Oncol; 2005 Jul; 35(7):375-9. PubMed ID: 15976068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head and neck cancer.
    Cannon DM; Lee NY
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):660-5. PubMed ID: 18037580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can dose reduction to one parotid gland prevent xerostomia?--A feasibility study for locally advanced head and neck cancer patients treated with intensity-modulated radiotherapy.
    Anand AK; Jain J; Negi PS; Chaudhoory AR; Sinha SN; Choudhury PS; Kumar R; Munjal RK
    Clin Oncol (R Coll Radiol); 2006 Aug; 18(6):497-504. PubMed ID: 16909975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric predictors of xerostomia for head-and-neck cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost technique.
    Amosson CM; Teh BS; Van TJ; Uy N; Huang E; Mai WY; Frolov A; Woo SY; Chiu JK; Carpenter LS; Lu HH; Grant WH; Butler EB
    Int J Radiat Oncol Biol Phys; 2003 May; 56(1):136-44. PubMed ID: 12694832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer.
    Dawson LA; Anzai Y; Marsh L; Martel MK; Paulino A; Ship JA; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1117-26. PubMed ID: 10725621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Study to Assess the Dosimetric Impact of the Anatomical Changes Occurring in the Parotid Glands and Tumour Volume during Intensity Modulated Radiotherapy using Simultaneous Integrated Boost (IMRT-SIB) in Head and Neck Squamous Cell Cancers.
    Ghosh A; Gupta S; Johny D; Vidyadhar Bhosale V; Pal Singh Negi M
    Cancer Med; 2021 Aug; 10(15):5175-5190. PubMed ID: 34159749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D-conformal-intensity modulated radiotherapy with compensators for head and neck cancer: clinical results of normal tissue sparing.
    Wendt TG; Abbasi-Senger N; Salz H; Pinquart I; Koscielny S; Przetak SM; Wiezorek T
    Radiat Oncol; 2006 Jun; 1():18. PubMed ID: 16790059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of intensity modulated radiation therapy (IMRT) treatment techniques for nasopharyngeal carcinoma.
    Cheng JC; Chao KS; Low D
    Int J Cancer; 2001 Apr; 96(2):126-31. PubMed ID: 11291096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Node Negative Target Volume Delineation on Contralateral Parotid Gland Dose Sparing Using IMRT in Head and Neck Cancer.
    Magnuson WJ; Urban E; Bayliss RA; Harari PM
    Technol Cancer Res Treat; 2015 Jun; 14(3):315-9. PubMed ID: 25782188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer.
    Hansen EK; Bucci MK; Quivey JM; Weinberg V; Xia P
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):355-62. PubMed ID: 16256277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geometric factors influencing dosimetric sparing of the parotid glands using IMRT.
    Hunt MA; Jackson A; Narayana A; Lee N
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):296-304. PubMed ID: 16904529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computed tomography number changes observed during computed tomography-guided radiation therapy for head and neck cancer.
    Feng M; Yang C; Chen X; Xu S; Moraru I; Lang J; Schultz C; Li XA
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1041-7. PubMed ID: 25832695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of an image-guided versus a non-image-guided setup approach in terms of delivered dose to the parotid glands in head-and-neck cancer IMRT.
    Duma MN; Kampfer S; Wilkens JJ; Schuster T; Molls M; Geinitz H
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1266-73. PubMed ID: 20350787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volume and dosimetric changes and initial clinical experience of a two-step adaptive intensity modulated radiation therapy (IMRT) scheme for head and neck cancer.
    Nishi T; Nishimura Y; Shibata T; Tamura M; Nishigaito N; Okumura M
    Radiother Oncol; 2013 Jan; 106(1):85-9. PubMed ID: 23337058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.